Kimberly Muller serves as executive director of CU Innovations, where she leads innovation initiatives for the University of Colorado Anschutz Medical Campus. Her business development responsibilities include investing, company creation, innovation management, forming key strategic industry partnerships, and licensing. She established large-scale industry collaborations in areas such as artificial intelligence and drug development. She also manages several funds, including an innovation grant fund, and a nearly $50 million venture fund.<\/p>\n
Ms. Muller joined CU from Yale University, where she was the deputy director of the Yale Entrepreneurial Institute, and managed new ventures in the Yale Office of Cooperative Research. During her tenure, Yale\u2019s Office of Cooperative Research started more than 70 new ventures that have raised over $5 billion in investor capital.<\/p>\n
Previously, Ms. Muller started and sold companies in the biotech, tech, and clean energy fields. Those companies included Curagen Corporation, acquired by Celldex Therapeutics; 454 Life Science, acquired by Roche; and Arbor Fuel, a biofuel company that utilized recombinant microorganisms for the production of ethanol and butanol. She began her career in New York as a patent attorney for Chadbourne and Parke, LLP.<\/p>\n
Ms. Muller has a master\u2019s degree in genetics and a law degree with highest honors from the University of Connecticut School of Law.<\/p>\n","protected":false},"template":"","class_list":["post-1538","team","type-team","status-publish","hentry"],"acf":[],"yoast_head":"\n